Research use only
RETATRUTIDE 30 mg
A synthetic research peptide described in the literature as a triple agonist of the GLP-1, GIP and glucagon receptors. The compound is at an experimental stage and is not approved as a medicinal product in the EU.
Specification
- Quantity: 30 mg per vial
- Form: Lyophilised powder
- Purity: ≥ 99% (HPLC)
- Analysis: HPLC and mass spectrometry, independent laboratory
- Batch (LOT): GP-20260525
- Best before (EXP): 05/2028
250,00 €
Price per unit · excluding delivery
Payment: cash on delivery only · Delivery: Econt or Speedy, 24–48 h
Storage and handling
- Lyophilised: at –20 °C, dark and dry
- Short term (up to 30 days): 2–8 °C
- After reconstitution: 2–8 °C, according to the laboratory’s protocol
- Avoid repeated freeze–thaw cycles
Documentation
A certificate of analysis (COA) is issued for every batch with exact values for purity, identity and molecular mass. It is accessible via the QR code on the packaging.
Research use only. The product is intended exclusively for in vitro laboratory use. It is not a medicinal product, food supplement or cosmetic product. It is not intended for human or animal consumption, nor for diagnostic or therapeutic purposes. Sold only to qualified researchers and scientific organisations.